Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 379 | 380 | 379 | 379 | 379 |
| Gross Profit | 379 | 380 | 379 | 379 | 379 |
| Operating Expenses | 27,542 | 20,240 | 20,232 | 16,989 | 15,479 |
| Operating Income | -27,163 | -19,860 | -19,853 | -16,610 | -15,100 |
| Interest Expense | 623 | 635 | 635 | 638 | 449 |
| Other Income | 63 | 72 | 51 | 186 | 313 |
| Pre-tax Income | -27,723 | -20,423 | -20,437 | -17,062 | -15,236 |
| Net Income Continuous | -27,723 | -20,423 | -20,437 | -17,062 | -15,236 |
| Net Income | $-27,723 | $-20,423 | $-20,437 | $-17,062 | $-15,236 |
| EPS Basic Total Ops | -0.54 | -0.43 | -0.46 | -0.42 | -0.56 |
| EPS Basic Continuous Ops | -0.54 | -0.44 | -0.46 | -0.42 | -0.44 |
| EPS Diluted Total Ops | -0.54 | -0.43 | -0.46 | -0.42 | -0.56 |
| EPS Diluted Continuous Ops | -0.54 | -0.44 | -0.46 | -0.42 | -0.44 |
| EBITDA(a) | $-27,034 | $-19,774 | $-19,832 | $-16,671 | $-15,187 |